AXDX
$9.50
Accelerate Diagnosti
($.32)
(3.26%)
AXDX
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  ($0.33)
Revenue:  $3.10 Mil
Tuesday
May 25
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AXDX reports earnings?
Beat
Meet
Miss

Where is AXDX's stock price going from here?
Up
Flat
Down
Stock chart of AXDX
Analysts
Summary of analysts' recommendations for AXDX
Score
Grade
Pivots
Resistance
$10.29
$10.11
$9.80

$9.62

Support
$9.31
$9.13
$8.82
Tweet
Growth
Description
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.